Skip to main content

SOPHiA GENETICS SA

SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
SEC CIK
0001840706

In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 35 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.

Q3 2022 vs. Q2 2022

How the institutions holding SOPHiA GENETICS SA changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of SOPH: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders34340
Shares21.6M20.8M−824.0K (−3.8%)
Value$78.1M$54.6M−$23.5M (−30.1%)

New holders (5)

Institutions that held SOPHiA GENETICS SA at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to SOPH in Q3 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC58,311$153.0K0.00%
Compagnie Lombard Odier SCmA6,055$16.0K0.00%
JPMorgan Chase & Co984$3.00K0.00%
BNP Paribas Arbitrage, SA489$1.29K0.00%
Alta Advisers Ltd1,000––

Sold out (5)

Institutions that held SOPHiA GENETICS SA at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of SOPH in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Barclays PLC57,751$209.0K
Two Sigma Investments, LP13,646$49.0K
Harel Insurance Investments & Financial Services Ltd.1,151$4.00K
Tower Research Capital LLC (TRC)528$2.00K
Total Clarity Wealth Management, Inc.581$2.00K